Pure Global

Glycated haemoglobin (HbA1c) IVD, control - UK MHRA Medical Device Registration

Glycated haemoglobin (HbA1c) IVD, control is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 118866. The device is manufactured by Shenzhen Lifotronic Technology Co., Ltd. from China, classified as In Vitro Diagnostic Device. The authorized representative in the UK is PureUKCA Ltd.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Glycated haemoglobin (HbA1c) IVD, control
MHRA Device ID: 118866โ€ขRef: 118866

Device Type

In Vitro Diagnostic Device

Devices

Glycated haemoglobin (HbA1c) IVD, control

Type

IVD General

Date Registered

Dec 9, 2021

Last Updated

Dec 22, 2022

Manufacturer Information

Address

Unit A, 4th Floor, Building 15, Yijing Estate, No.1008 Songbai Road, Nanshan District

shenzhen, China

Created Date

Dec 9, 2021

Authorized Representative

Relationship Type

UK Responsible Person

Address

59 St. Martin's Lane

London, Middlesex, England, United Kingdom

Postcode: WC2N 4JS

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing